“Tickborne Diseases Of The United States” – Resources From The Centers For Disease Control And Prevention

Tickborne Diseases of the United States from the Centers For Disease Control And Prevention:

ID Your Tick: Photos and illustrations to help you identify different types of ticks.

Tick Bite Prophylaxis: Guidance for clinicians:

The Infectious Disease Society of America (IDSA) does not generally recommend antimicrobial prophylaxis for prevention of Lyme disease after a recognized tick bite. However, in areas that are highly endemic for Lyme disease, a single dose of doxycycline may be offered to adult patients (200 mg) who are not pregnant and to children older than 8 years of age (4 mg/kg up to a maximum dose of 200 mg) when all of the following circumstances exist:

  1. Doxycycline is not contraindicated.
  2. The attached tick can be identified as an adult or nymphal I. scapularis tick.
  3. The estimated time of attachment is ≥36 h based on the degree of engorgement of the tick with blood or likely time of exposure to the tick.
  4. Prophylaxis can be started within 72 h of tick removal.
  5. Lyme disease is common in the county or state where the patient lives or has recently traveled, (i.e., CT, DE, MA, MD, ME, MN, NH, NJ, NY, PA, RI, VA, VT, WI).

Antibiotic treatment following a tick bite is not recommended as a means to prevent anaplasmosis, babesiosis, ehrlichiosis, or Rocky Mountain spotted fever. There is no evidence this practice is effective, and it may simply delay onset of disease. Instead, persons who experience a tick bite should be alert for symptoms suggestive of tickborne illness and consult a physician if fever, rash, or other symptoms of concern develop.

Tularemia prophylaxis is recommended only in cases of laboratory exposure to infectious materials:

  • Doxycycline (100 mg orally BID X 14 days) is generally recommended for prophylaxis in adults.
  • Ciprofloxacin (500 mg orally BID) is not FDA-approved for prophylaxis of tularemia but has demonstrated efficacy in various studies, and may be an alternative for patients unable to take doxycycline.

Guidance For Healthcare Providers: Symptoms, diagnostics, treatment and additional references – A list of tickborn Diseases of the United States from the Centers For Disease Control and Prevention:

*Treatment

*Anaplasmosis, ehrlichiosis, and Rocky Mountain spotted fever are treated in the same manner with doxycycline.† Clinical suspicion of any of these diseases is sufficient to begin treatment. Delay in treatment may result in severe illness and even death. The regimens listed below are guidelines only and may need to be adjusted depending on a patient’s age, medical history, underlying health conditions, pregnancy status, or allergies. Consult an infectious disease specialist in cases of pregnancy or documented life-threatening allergies to doxycycline.

*NOTE: Use doxycycline as the first-line treatment for suspected RMSF in patients of all ages. The use of doxycycline to treat suspected RMSF in children is recommended by both the CDC and the American Academy of Pediatrics Committee on Infectious Diseases. Use of antibiotics other than doxycycline increases the risk of patient death. At the recommended dose and duration needed to treat RMSF, no evidence has been shown to cause staining of permanent teeth, even when five courses are given before the age of eight.

For Health Care Providers:

Tickborne Diseases of the US: A Reference Manual for Health Care Providers, Fourth Edition (2017)[PDF – 3 MB, 21 pages]

Provides concise, comprehensive, and updated information about the prevention, identification, and treatment of tickborne diseases.

 

This entry was posted in Family Medicine, Infectious Diseases, Internal Medicine. Bookmark the permalink.